InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Martin Robert Nathaniel, Chief Financial Officer. Insider active across 2 companies, notably M.d.c. Holdings, INC.. In total, 13 filings have been logged. Breakdown: 0 buy · 2 sells. Total volume traded: €206k. Activity tracked since 12 August 2021. The latest transaction was disclosed on 29 February 2024 (Don). Regulator: SEC (Form 4). The full history is openly available.
Declarations13 total
227,435 sharesCommon Stock $.01 Par ValueSEC:0000950142-24-001142:0
30,000 shares0Common Stock $.01 Par ValueSEC:0001062993-24-005033:0
35,000 shares0Common Stock $.01 Par ValueSEC:0001062993-24-002006:0
19,839 shares@ US$21.4034.5% of flowCommon Stock $.01 Par ValueSEC:0001062993-23-015419:0
13,226 shares@ US$23.4625.3% of flowCommon Stock $.01 Par ValueSEC:0001062993-23-010594:0
1,356 shares@ US$40.334.5% of flowCommon Stock $.01 Par ValueSEC:0001062993-23-002251:0
1,360 shares@ US$46.6914.1% of flowCommon Stock $.01 Par ValueSEC:0001062993-22-002661:0
1,360 shares@ US$46.695.0% of flowCommon Stock $.01 Par ValueSEC:0001062993-22-002661
990 shares@ US$46.2410.2% of flowCommon Stock $.01 Par ValueSEC:0001062993-22-002185:0
990 shares@ US$46.243.6% of flowCommon Stock $.01 Par ValueSEC:0001062993-22-002185
2,309 shares@ US$52.2525.7% of flowCommon Stock $.01 Par ValueSEC:0001062993-21-007497:0
2,309 shares@ US$52.259.2% of flowCommon Stock $.01 Par ValueSEC:0001062993-21-007497
4,847 sharesCommon Stock $.01 Par ValueSEC:0001643076-16-000009:0
13 of 13 declarations
About Martin Robert Nathaniel
Robert Nathaniel Martin is the Chief Financial Officer and Senior Vice President of M.D.C. Holdings, Inc. He is responsible for the financial management of the company, overseeing accounting operations and financial reporting. Robert Nathaniel Martin plays a key role in developing financial strategies to support the growth of M.D.C.
